Law Daily Report

AbbVie halts late-stage trial for lung cancer drug Rova-T

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

REUTERS: AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trialREUTERS: Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trialREUTERS: Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trialREUTERS: Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »